Cancer Cell International

Article	Citations
Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia	420
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma	285
Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway	248
Human amniotic epithelial cells exert anti-cancer effects through secretion of immunomodulatory small extracellular vesicles (sEV)	231
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7	178
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation	137
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules	128
miR-196a-5p promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting LIFR	120
Evaluation of functional magnetic resonance APT and DKI imaging for breast cancer	113
Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis	106
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression	100
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer	99
Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing	93
KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma	88
Unraveling the role of the solute carrier family in hepatocellular carcinoma: mechanisms and therapeutic prospects	88
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies	86
Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells	84
The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C	82
TAGLN: a stiffness-driven prognostic biomarker for metastatic colorectal cancer	82
Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics	81
Targeting the CCL5/CCR5-PI3K-AKT axis suppresses hepatic stellate cell-induced breast cancer metastasis	80
Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways	79
ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR	77
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75	75
Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer	73

Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer	70
Shared molecular mechanisms of common differentially expressed genes (C-DEGs) linking gallbladder stones to carcinogenesis: integrated bioinformatics and experimental validation	70
Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in HNSC	67
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines	66
Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma	64
CDK4 inhibition by luteolin enhances lenvatinib sensitivity in HCC via Wnt/β-catenin modulation	64
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma	64
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer	63
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors	59
Molecular mechanisms of microRNA-216a during tumor progression	59
Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma	58
Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT	58
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities	57
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives	56
Transcription factor MYB regulates glycolysis to promote the transfer and malignant progression of gastric cancer through the SSBP2/ISL1 axis	55
MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome	55
Melanoma biology and treatment: a review of novel regulated cell death-based approaches	55
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling	54
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway	54
Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers	53
Amino acid-based risk stratification model improves prognostic precision in diffuse large B-cell lymphoma	52
SETDB1 promotes gastric cancer progression via UPR and mTOR pathway	52
Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells	52
Venetoclax synergizes with Wnt/β-catenin inhibitor C-82 in acute myeloid leukemia by increasing the degradation of Mcl-1 protein	51
Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells	50
Etiology of polyploid giant cancer cells: a new frontier in cancer biology	50
Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC	49
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics	48
Hepatocellular carcinoma drug resistance models	48
Cuproptosis: a promising new target for breast cancer therapy	47
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia	46
[email protected] nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor	46
C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer	45
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1	45
The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axis	45
Microglia-mediated drug substance transfer promotes chemoresistance in brain tumors: insights from an in vitro co-culture model using GCV/Tk prodrug system	45
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma	45
The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma	45
Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis	44
LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis	44
Co-delivery of camptothecin and SH3RF3-AS1 SiRNA for glioma synergistic therapy	44
Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease	43
Development of a G2/M checkpoint subtype classifier for guiding precision therapy in liver hepatocellular carcinoma patients	42
Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China	42
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagy	42
CAR-T cell combination therapy: the next revolution in cancer treatment	42
ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer	41
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer	40
Oncogenic roles of the lncRNA LINC00460 in human cancers	40
Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma	40

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes	40
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing	39
Deapioplatycodin D inhibits glioblastoma cell proliferation by inducing BNIP3L-mediated incomplete mitophagy	39
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma	39
Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation	39
Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic	38
Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer	37
Identification of CD4_Naive cells related gene FMO4 as a positive regulator of the poor prognosis of septic CRC patients	37
Pomegranate juice and punicalagin-mediated chemoprevention of hepatocellular carcinogenesis via regulating miR-21 and NF-κB-p65 in a rat model	37
Divergent effects of topical deferoxamine treatment on skin and cancer cells uncovers its potential as a safe radioprotective agent in oncological applications	37
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	36
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis	36
STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment	36
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment	36
Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness	35
DNA damage response signature-based prognostic genes for intrahepatic cholangiocarcinoma: a combined analysis of machine learning and biological experiments	35
Retraction Note: circRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis	35
Spatial and single-cell analyses uncover links between ALKBH1 and tumor-associated macrophages in gastric cancer	34
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model	34
Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy	34
The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications	34
Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma	33
Ferroptosis: insight into the treatment of hepatocellular carcinoma	33
Predicting survival of persons with newly-diagnosed multiple myeloma	33
Exploring the oncogenic mechanism of plasmacytoma variant translocation 1 (PVT1) gene in solid cancers; emphasis on microRNA regulation pathways	33
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review	33
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms	33
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC	33
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential	32
SLC9A9 links tumor immune infiltration to therapeutic response in colorectal cancer with emphasis on mismatch repair proficient subtype	32
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells	32
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility	32
Personalized chemotherapy guided by drug sensitivity of circulating tumor cells improves outcomes in advanced biliary tract cancer	32
Construction of anti-tumor immune gene signature for HNSCC and identification of 4'-Hydroxywogonin as a potential immunotherapy combination drug	32
Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis	31
Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA/PLK1 pathway	31
E3 ubiquitin ligase HECW2: a promising target for tumour therapy	31
Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer	31
Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads	31
Retraction Note: LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146	30
Circular RNA circPTPRF promotes the progression of GBM via sponging miR-1208 to up-regulate YY1	30
Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study	29
Dysregulation of ferroptosis-related genes and the ACSL4-mediated ferroptosis-PD-L1 axis in prostate cancer pathogenesis	29
Luteolin: a flavonoid with a multifaceted anticancer potential	29
Migration and invasion of cancer stem cells are prevented by low-intensity pulsed ultrasound therapy	29
Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population	29
Retraction Note: MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression	29
PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway	29
The upregulation of VGF enhances the progression of oral squamous carcinoma	29
Specificity protein 1 initiates epithelial-mesenchymal transition of circulating tumor cells to inhibit metastasis in prostate cancer	28
The role of LncRNAs in tumor immunotherapy	28
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma	28
The impact of gut bacteria producing long chain homologs of vitamin K2 on colorectal carcinogenesis	27
Machine learning for postoperative complication prediction and early recurrence risk assessment across cancer types: a systematic review and meta-analysis	27
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	27
Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy	27
Interaction of AURKA with TRIM28 revives dormant LSCC cells via Akt signaling pathway to promote LSCC metastasis	27
Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis	27
Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy	27
Integrated bioinformatics analysis of SEMA3C in tongue squamous cell carcinoma using machine-learning strategies	27
Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression	27
Identification and validation of a prognostic model based on three TLS-Related genes in oral squamous cell carcinoma	26
Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects	26
Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers	26
PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function	26
Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells	26
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human gliob	25
Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitro	25
Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways	25
Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma	25
Correction: TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma	25
circ_0061265 competitively binds to microRNA-885-3p to promote the development of gastric cancer by upregulating AURKA expression	25
Helicobacter pylori promotes gastric cancer progression via UPP1-mediated uridine bypass of glycolysis	25
Retraction Note: Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis	24
The emerging role of TROP2 as a diagnostic and prognostic biomarker in bladder tumor	24
Association of whole grain food consumption with lung cancer risk: a prospective cohort study	24
Salivary genetic biomarkers of lung cancer: a systematic review and meta-analysis of the diagnostic accuracy	24
RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway	24
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B	24
Retraction Note: Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma	24

The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression	24
Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway?	24
A review on the role of mir-16-5p in the carcinogenesis	24
Novel insights into the interaction between IGF2BPs and ncRNAs in cancers	24
Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells	24
High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma	24
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation	24
TGFBI deficiency facilitates tumor associated macrophages M2 polarization and angiogenesis to promote pancreatic neuroendocrine neoplasms progression	24
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling	23
Exosomal circPOLK promotes metastasis of NSCLC cells via regulating mir-1204/SOX8 axis	23
Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma	23
NSC777201 exhibits anticancer activity against colorectal cancer cells by inducing multiple types of cell death	23
Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer	23
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade	23
Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy	23
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation	22
Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges	22
Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma	22
Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1	22
miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling	22
Retraction Note: Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription	22
8-Chloro-adenosine inhibits breast cancer progression by inducing ferroptosis via the ADAR1/miR-101-3p/SLC7A11 axis	22
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma	22
LncRNA SNHG1: role in tumorigenesis of multiple human cancers	22
Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression	21
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy	21
Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer	21
Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer	21
Environmental interpretation of the impact of vehicle emissions on prostate cancer progression	21
Unraveling the oncogenic and immunomodulatory roles of GINS1: a systematic pan-cancer study	21
Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine	21
A review of exercise-induced epigenetic modifications in prostate tissue: implications for gene expression and tumor progression in prostate cancer	21
Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma	21
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review	21
Single-cell sequencing in bladder cancer: new insights from tumor cell diversity to individualized treatment strategies	21
Impact of β3-adrenergic receptor agonist on tumor progression and metastasis in renal cell carcinoma models	21
LTCONS_00014107-miR-29b-2-3p-GPR37 axis promotes heat stimulation induced esophageal carcinogenesis	21
LIS1 mediated Schwann cell reprogramming enhances perineural invasion by activating the serine/NMDAR/AKT signaling pathway in head and neck squamous carcinoma	21
Emerging roles for lncRNA-NEAT1 in colorectal cancer	21
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1	21
The role of m6A modification in non-small cell lung cancer: functional insights and impact on therapy resistance	21
Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing	21
Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene	21
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures	21
Novel a new prognostic model of thyroid carcinoma based on macrophage and cuproptosis-related lncRNA	21
Methylome profiling reveals context-dependent chemo-resistance mechanisms and enhances risk stratification in AML	21
An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer	21
LncRNA SPINT1-AS1 enhances the Warburg effect and promotes the progression of osteosarcoma via the miR-135b-5p/PGAM1 axis	21
Correction to: SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial–mesenchymal transition	21
Oncogenic LINC00698 suppresses apoptosis of melanoma stem cells to promote tumorigenesis via LINC00698-miR-3132-TCF7/hnRNPM axis	20
Disruption of DMD gene leads to altered calcium homeostasis and metabolic shift impacting gastric Cancer cell proliferation and migration	20
Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact on glioma progression	20
Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors	20
Transforming bone cancer treatment: a comprehensive review of green-synthesized metal nanoparticles	20
Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma	20
Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses	20
Prognostic evaluation and experimental validation of cuproptosis-related hub genes identified through weighted gene co-expression network analysis in uveal melanoma	20
MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells	20
Targeted suppression of DNA polymerase θ enhances calcium flux and triggers intrinsic apoptosis in gastric cancer	20
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways	20
UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression	20
Invasiveness-related microRNA expression in glioma: associations with clinical outcomes, tumor burden, and health-related quality of life	20
A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma	20
MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression	20
Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression	20
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications	20
Methylomics and cancer: the current state of methylation profiling and marker development for clinical care	20
Targeting oral tumor microenvironment for effective therapy	19
Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis	19
ALDH18A1 regulates glutamine metabolism and tumor microenvironment in the attenuation of clear cell renal cell carcinoma	19
Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma	19
TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy	19
Correction: Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination	19
NUDT1 drives osteosarcoma progression and serves as a robust predictor of clinical outcomes	19
Integrating multi-omics data revealing LIMK1 as a metastatic biomarker in LUAD patients with brain metastasis	19
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients	19
Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis	19
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review	19
P21-activated kinase 4: a potent oncogene, molecular mechanisms and opportunities for targeted therapy	19
Recent advances in the detection of glioblastoma, from imaging-based methods to proteomics and biosensors: A narrative review	19
MDM2: current research status and prospects of tumor treatment	19
Paris saponin VII suppresses osteosarcoma progression by targeting VEGFR2 and PD-L1 to enhance anti-angiogenic and immunotherapeutic efficacy	19
Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?	19
Very long-chain fatty acids accumulate in breast cancer tissue and serum	19
Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells	19
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma	19
CircITGA7 overexpression suppresses HCC progression via miR-330/BCL11B axis regulation	19
Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer	19
Green-synthesized MnFe₂O₄/GO nanocomposites: structural characterization, cytotoxicity, and potential for targeted cervical cancer therapy	19
Regulatory mechanisms and clinical implications of PIWI-interacting RNAs (piRNAs) in major digestive tract cancers	18
Mechanisms and intervention strategies of microenvironment-mediated drug resistance in multiple myeloma	18
ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma	18
Correction: TRPM2: a pivotal player in tumor progression and a promising therapeutic target	18
Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients	18
Development and validation of a diagnostic machine learning model for gastric cancer risk based on double-negative T cell-related features	18